Bellevue Life Sciences Acquisition Corp. Rights
BLACR
BLACR was delisted on the 14th of February, 2025.
31 hedge funds and large institutions have $798K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 0 closing their positions.
11% more funds holding
Funds holding: 28 → 31 (+3)
5% less capital invested
Capital invested by funds: $838K → $798K (-$39.8K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOA
Sea Otter Advisors
Miami,
Florida
|
+$18.6K |
| 2 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
+$3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$13.7K |
| 2 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$932 |
| 3 |
FTUS
Flow Traders U.S.
New York
|
-$414 |
| 4 |
CS
Clear Street
New York
|
-$95 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
26
Bulldog Investors
Saddle Brook,
New Jersey
| $2.67K | +$3K | +19,640 | New |
|
|
WC
27
Wealthspring Capital
West Harrison,
New York
| $2.24K | -$932 | -6,100 | -27% |
|
|
FTUS
28
Flow Traders U.S.
New York
| $2K | -$414 | -2,708 | -19% |
|
|
CCM
29
Condor Capital Management
Martinsville,
New Jersey
| $1.41K | – | – | – |
|
30
Bank of America
Charlotte,
North Carolina
| $14 | – | – | – |
|
|
31
UBS Group
Zurich,
Switzerland
| $3 | +$3 | +22 | New |
|
BLACR Hedge Fund Activity: Q1 2024 in Review
31 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Rights (BLACR) for Q1 2024, worth a combined $798K — down 4.8% from $838K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BLACR positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 4 trimmed.
The largest buyer was Sea Otter Advisors, opening a new position worth an estimated $18.6K. The largest seller was Spartan Fund Management, cutting an estimated $13.7K.
- 31 institutional investors held Bellevue Life Sciences Acquisition Corp. Rights (BLACR) as of Q1 2024, up from 28 in Q4 2023.
- Funds reported $798K of Bellevue Life Sciences Acquisition Corp. Rights stock for Q1 2024, down 4.8% quarter-over-quarter.
- 4 funds opened new Bellevue Life Sciences Acquisition Corp. Rights positions in Q1 2024 and 0 closed out, a net change of +4 holders.
- The largest Bellevue Life Sciences Acquisition Corp. Rights buyer in Q1 2024 was Sea Otter Advisors, an estimated $18.6K added.
- The largest Bellevue Life Sciences Acquisition Corp. Rights seller in Q1 2024 was Spartan Fund Management, an estimated $13.7K sold.
Based on aggregated 13F filings for Q1 2024.